
	Showcasing the most successful biopharmaceutical companies in France.
BioFrance is a growing and successful biotech community. France has established itself as a contender among Europe’s leading biopharmaceutical hotbeds, ranking fifth in Phase III public company pipelines in Europe, according to Ernst & Young. With a rise in venture capital, BioFrance shows promise of continuing expansion and development of products and research. Join the World Discussion Forum

Hotbed News

AB Science (AB.PA): Launch of a Phase 3 Clinical Trial in Alzheimer's Disease Monday, May 20, 2013 More...

Stentys Enrolls First Heart Attack Patient in Pivotal U.S. Clinical Trial Monday, May 20, 2013 More...

Bickering Continues Over Sanofi (France) (SAN.PA) R&D Site Monday, May 20, 2013 More...

Sanofi (France) (SAN.PA) Plans to File JAK2 Inhibitor After Positive Phase III Monday, May 20, 2013 More...

Mauna Kea Technologies Announces Strongest Scientific Exposure Ever With More Than 40 Communications on Cellvizio® at Digestive Disease Week 2013 Friday, May 17, 2013 More...

DBV Technologies and Stallergenes, S.A. (GENP.PA) Enter Into Partnership for the Development of Innovative Treatment of Respiratory Allergies Friday, May 17, 2013 More...

The Start-Up ElsaLys Biotech, a New Player in the Therapeutic Monoclonal Antibody Arena, Announces the First Round of Financing With TRANSGENE (TRGNY) and Sofimac Partners Friday, May 17, 2013 More...

EOS Imaging (Formerly Known as biospace med) Shown to offer Most Accurate Lower Limb Images Eith Lowest Radiation Dose in New Study Thursday, May 16, 2013 More...

Sanofi (France) (SAN.PA) and Regeneron Pharmaceuticals, Inc. (REGN) Announce Patient Enrollment in Two Phase 3 Trials with Sarilumab in Rheumatoid Arthritis (RA) Thursday, May 16, 2013 More...

PIP Breast Implant Founder "Should Get Four Years in Jail" Thursday, May 16, 2013 More...

Showcasing the most successful biopharmaceutical companies in France.